SUPN — Supernus Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(SUPN)

Supernus Pharmaceuticals, Inc.

Live chart and latest SUPN stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

SUPN News

The Motley Fool

Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year

Mar 27, 2026 StockStory

3 Reasons SUPN is Risky and 1 Stock to Buy Instead

Mar 11, 2026 Quiver Quantitative

Supernus Pharmaceuticals (SUPN) Releases Q4 2025 Earnings: Revenue Up, Operating and Net Losses

Mar 2, 2026 Yahoo Finance

Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Momentum And Pipeline Progress

Feb 16, 2026 Stock Titan

[8-K] SUPERNUS PHARMACEUTICALS, INC. Reports Material Event

Apr 7, 2026 Stock Traders Daily

Precision Trading with Supernus Pharmaceuticals Inc. (SUPN) Risk Zones

Mar 10, 2026 simplywall.st

Recent 3.5% pullback isn't enough to hurt long-term Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders, they're still up 64% over 5 years

Jan 24, 2026 Seeking Alpha

Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)

Feb 1, 2026 TradingView — Track All Markets

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q4 CY2025: Strong Sales

Feb 24, 2026 Stock Titan

Vanguard disaggregates holdings after internal realignment (SUPN)

Mar 27, 2026 Yahoo Finance

Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy

Oct 29, 2025 The Motley Fool

Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back

Dec 15, 2025 TradingView — Track All Markets

Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect

Feb 22, 2026 Stock Titan

[Form 4] SUPERNUS PHARMACEUTICALS, INC. Insider Trading Activity

Mar 18, 2026 Stock Titan

Supernus (NASDAQ: SUPN) CEO-linked KBT Trust sells 35,000 shares under 10b5-1 plan